Search Options Stock News and Analysis from Schaeffer's

Pharmaceutical Stock Jumps on FDA Approval

https://www.schaeffersresearch.com/content/news/2022/09/12/pharmaceutical-stock-jumps-on-fda-approval

9/12/2022 10:23 AM

Bristol-Meyers Squibb Co (NYSE:BMY) is up 6.4% at $74.62 at last glance and earlier traded as high as $75.99, after the U.S. Food and Drug Administration (FDA) approved Sotyktu, the company's oral tre...

Red-Hot Bristol-Myers Squibb Stock Has Plenty of Room to Run

https://www.schaeffersresearch.com/content/options/2022/04/06/red-hot-drug-stock-has-room-to-run

4/6/2022 2:01 PM

The shares of Bristol-Myers Squibb Co (NYSE:BMY) have been on a steady uptrend over the last several months, while boasting low implied volatility (IV). What’s more, the sto...

BMY Looks to Launch Higher After Cancer Treatment Approval

https://www.schaeffersresearch.com/content/analysis/2021/06/30/bmy-looks-to-launch-higher-after-cancer-treatment-approval

6/30/2021 9:59 AM

Bristol-Myers Squibb Co (NYSE:BMY) is a global biopharmaceutical company that focuses on the discovery, development, and delivery of medications. The company manufactures prescription pharmaceuticals ...

Biopharmaceutical Stock Flat Despite Upgrade to "Buy"

https://www.schaeffersresearch.com/content/news/2021/04/13/biopharmaceutical-stock-flat-despite-upgrade-to-buy

4/13/2021 9:13 AM

The shares of biopharmaceutical name Bristol-Myers Squibb Co (NYSE:BMY) are up 0.6% at $63.07 in pre-market trading, after Truist Securities upgraded the stock to "buy" from hold," with a price-target...

BMY Flashing Bull Signal Ahead of Earnings

https://www.schaeffersresearch.com/content/analysis/2021/02/01/bmy-flashing-bull-signal-ahead-of-earnings

2/1/2021 2:22 PM

The shares of Bristol-Myers Squibb Co (NYSE:BMY) are up 1.6% at $62.39 at last check, just ahead of the pharmaceutical name's fourth-quarter earnings, due out before the open on Thursday, Feb. 4. In ...

PEOPLE ALSO SEARCH FOR